Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion
Eli Lilly has agreed to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio.
Connecting Global Economies
Flash News
How to watch Rayo Vallecano vs. Barcelona in the U.S.: TV channel and streaming options for August 31
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion
Ukraine prepares for talks with Trump envoys as Kyiv reels from deadly strikes
Kalshi looks international, partners with brokerage Alpaca
Chappell Roan Unveils Sleek Bob at Olivia Rodrigo’s Music Festival
‘It's put up or shut up time’: Battleground Republicans want the Darline treatment
U.S. Open 2026 live updates: Day 2 latest with Carlos Alcaraz, Aryna Sabalenka and Ben Shelton in action today
Tech, Media & Telecom Roundup: Market Talk
Trump calls for ‘punishment’ of NBC journalist over endorsement coverage
Gemini not at fault for collapse of Earn lending program, arbitrator says
Monday, August 31, 2026